… The treatment of acute myeloid leukemia (AML) in first relapse is associated with unsatisfactory
… decision making and evaluation of investigational treatment strategies at relapse of AML. …

… acute myeloid leukemia (AML) in first relapse. Thirty-one trials containing at least 20 patients
in first relapse and information on patient age, duration of first … patients in first relapse. The …

… Among 1,535 patients with AML who achieved CR, 1,015 (66%) relapsed, with … first relapse,
with age, cytogenetics, and duration of CR1 as important predictors of survival in first relapse…

… In this single institution study, we analyzed our results with reinduction therapy for AML in
first relapse and investigated the role of patient and disease-related variables in determining …

… with CD33-positive acute myeloid leukemia (AML) in untreated first relapse. PATIENTS AND
METHODS: The study population comprised 142 patients with AML in first relapse with no …

To provide data for future drug evaluation, we analyzed the outcome of 393 patients aged
50 years or older (median, 64 years) with AML in first relapse after treatment in recent ALFA …

… Despite improvements in acute myeloid leukemia (AML) therapy, relapse is still the most
challenging aspect in AML. While 10–40% of younger AML patients are primarily refractory to …

… For patients in first relapse, the prognosis mainly depends on the time of relapse. If it is early,
… Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia. …

… In a retrospective multicenter study on 150 AML patients aged over 60 years in first relapse,
we found that 66% of them had been given aggressive therapy aimed at achieving CR2, …

… and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia
group … after induction in patients with acute myeloid leukemia: prognostic significance and the …